Single high dose irradiation induces cell cycle arrest and apoptosis in human hepatocellular carcinoma cells through the Ras/Raf/MEK/ERK pathways

References

• Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ, Zook J, Johnstone PA, Cardenes HR. 2011. Stereotactic body radiation for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 81(4):e447–e453.
   PubMed Web of Science ®Google Scholar
• Asati V, Mahapatra DK, Bharti SK. 2016. PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathwaysinhibitors as anticancer agents: Structural and pharmacological perspectives. Eur J Med Chem. 109:314–341.
   PubMed Web of Science ®Google Scholar
• Bujold A, Massey CA, Kim JJ, Brierley J, Cho C, Wong RK, Dinniwell RE, Kassam Z, Ringash J, Cummings B, et al. 2013. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. JCO. 31(13):1631–1639.
   PubMed Web of Science ®Google Scholar
• Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, et al. 2009. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 10(1):25–34.
   PubMed Web of Science ®Google Scholar
• Cheng JC, Wu JK, Huang CM, Huang DY, Cheng SH, Lin YM, Jian JJ, Yang PS, Chuang VP, Huang AT. 2002. Radiation-induced liver disease after radiation for hepatocellular carcinoma: Clinical manifestation and dosi-metric description. Radiother Oncol. 63(1):41–45.
   PubMed Web of Science ®Google Scholar
• Ciccarelli C, Vulcano F, Milazzo L, Gravina GL, Marampon F, Macioce G, Giampaolo A, Tombolini V, Di Paolo V, Hassan HJ, et al. 2016. Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population. Mol Cancer. 15(1):16–26897742.
   PubMedGoogle Scholar
• Gollob JA, Wilhelm S, Carter C, Kelley SL. 2006. Role of Raf kinase in cancer: Therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Semin Oncol. 33(4):392–406.
   PubMed Web of Science ®Google Scholar
• Hoffmann K, Shibo L, Xiao Z, Longerich T, Büchler MW, Schemmer P. 2011. Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma. Anticancer Res. 31(11):3883–3890.
   PubMed Web of Science ®Google Scholar
• Jackman M, Lindon C, Nigg EA, Pines J. 2003. Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat Cell Biol. 5(2):143–148.
   PubMed Web of Science ®Google Scholar
• Jacob J, Nguyen F, Deutsch E, Mornex F. 2014. Stereotactic body radiation therapy in the management of liver tumours. Cancer Radiother. 18(5-6):486–494.
   PubMed Web of Science ®Google Scholar
• Jang WI, Kim MS, Bae SH, Cho CK, Yoo HJ, Seo YS, Kang JK, Kim SY, Lee DH, Han CJ, et al. 2013. High-dose stereotactic body radiation correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma. Radiat Oncol. 8(1):250.
   PubMedGoogle Scholar
• Lee DH, Park KI, Park HS, Kang SR, Nagappan A, Kim JA, Kim EH, Lee WS, Hah YS, Chung HJ, et al. 2012. Flavonoids isolated from Korea citrus aurantium L. induce G2/M phase arrest and apoptosis in human gastric cancer AGS cells. Evid Based Complement Alternat Med. 2012:515901.
   PubMedGoogle Scholar
• Liu L, Cao Y, Chen C, Zhang X, Mc Nabola A, Wilkie D, Wilhelm S, Lynch M, Carter C. 2006. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res. 66(24):11851–11858.
   PubMed Web of Science ®Google Scholar
• Maingon P, Nouhaud É, Mornex F, Créhange G. 2014. Stereotactic body radiation therapy for liver tumours. Cancer/Radiothérapie. 18(4):313–319.
   Google Scholar
• Marampon F, Gravina GL, Popov VM, Scarsella L, Festuccia C, La Verghetta ME, Parente S, Cerasani M, Bruera G, Ficorella C, et al. 2014. Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines. Int J Oncol. 44(1):285–294.
   PubMed Web of Science ®Google Scholar
• Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW. 2012. Radiation-induced vascular damage in tumors: Implications of vascular damage in ablative hypofractionated radiation (SBRT and SRS). Radiat Res. 177(3):311–327.
   PubMed Web of Science ®Google Scholar
• Scorsetti M, Comito T, Cozzi L, Clerici E, Tozzi A, Franzese C, Navarria P, Fogliata A, Tomatis S, D’Agostino G, et al. 2015. The challenge of inoperable hepatocellular carcinoma (HCC): Results of a single-institutional experience on stereotactic body radiation therapy (SBRT). J Cancer Res Clin Oncol. 141(7):1301–1309.
   PubMed Web of Science ®Google Scholar
• Stark GR, Taylor WR. 2006. Control of the G2/M transition. Mol Biotechnol. 32(3):227–248.
   PubMed Web of Science ®Google Scholar
• Tangutur AD, Kumar D, Krishna KV, Kantevari S. 2017. Microtubule targeting agents as cancer chemotherapeutics: An overview of molecular hybrids as stabilizing and destabilizing agents. Curr Top Med Chem. 17(22):2523–2537.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. 2015. Global cancer statistics. CA Cancer J Clin. 65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Wang Y, Nie H, Zhao X, Qin Y, Gong X. 2016. Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways. BMC Cancer. 16(1):742–27654866.
   PubMedGoogle Scholar
• Xu L, Wang L, Wen Z, Wu L, Jiang Y, Yang L, Xiao L, Xie Y, Ma M, Zhu W, et al. 2016. Caveolin-1 is a checkpoint regulator in hypoxia-induced astrocyte apoptosis via Ras/Raf/ERK pathway. Am J Physiol Cell Physiol. 310(11):C903–910.
   PubMed Web of Science ®Google Scholar
• Yamada H, Abe T, Li SA, Tago S, Huang P, Watanabe M, Ikeda S, Ogo N, Asai A, Takei K. 2014. N′-[4-(dipropylamino) benzylidene]-2-hydroxybenzohydrazide is a dynamin GTPase inhibitor that suppresses cancer cell migration and invasion by inhibiting actin polymerization. Biochem Bioph Res C. 443(2):511–517.
   PubMed Web of Science ®Google Scholar
• Yang S, Liu G. 2017. Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma. Oncol Lett. 13(3):1041–1047.
   PubMed Web of Science ®Google Scholar